Christian Valdes‐Cortez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christian Valdes‐Cortez has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Facundo Ballester
IRIMED, IIS-La Fe-Universitat de Valencia (UV), 46100 Burjassot, Spain
3 shared publications Javier Vijande
IRIMED IIS La Fe ‐ University of Valencia Valencia Spain
3 shared publicationsJose Perez‐Calatayud
IRIMED IIS La Fe ‐ University of Valencia Valencia Spain
3 shared publications- Yury Niatsetski
Elekta AB, Stockholm, Stockholm, SWEDEN
3 shared publications Facundo Ballester
IRIMED IIS La Fe ‐ University of Valencia Valencia Spain
2 shared publications- Javier Vijande
Departamento de Física Atómica, Molecular y Nuclear, Universitat de Valencia (UV), Burjassot, Spain
2 shared publications
Latest Publications
- 17 June 2022
- Published by Wiley in Medical Physics
- Vol. 49 (8) , 5576-5588
A Monte Carlo study of the relative biological effectiveness in surface brachytherapy
Purpose This work aims to simulate clustered DNA damage from ionizing radiation and estimate the relative biological effectiveness (RBE) for radionuclide (rBT)- and electronic (eBT)-based surface brachytherapy through a hybrid Monte Carlo (MC) approach, using realistic models of the sources and applicators. Methods Damage from ionizing radiation has been studied using the Monte Carlo Damage Simulation algorithm using as input the primary electron fluence simulated using a state-of-the-art MC code, PENELOPE-2018. Two Ir-192 rBT applicators, Valencia and Leipzig, one Co-60 source with a Freiburg Flap applicator (reference source), and two eBT systems, Esteya and INTRABEAM, have been included in this study implementing full realizations of their geometries as disclosed by the manufacturer. The role played by filtration and tube kilovoltage has also been addressed. Results For rBT, an RBE value of about 1.01 has been found for the applicators and phantoms considered. In the case of eBT, RBE values for the Esteya system show an almost constant RBE value of about 1.06 for all depths and materials. For INTRABEAM, variations in the range of 1.12-1.06 are reported depending on phantom composition and depth. Modifications in the Esteya system, filtration, and tube kilovoltage give rise to variations in the same range. Conclusions Current clinical practice does not incorporate biological effects in surface brachytherapy. Therefore, the same absorbed dose is administered to the patients independently on the particularities of the rBT or eBT system considered. The almost constant RBE values reported for rBT support that assumption regardless of the details of the patient geometry, the presence of a flattening filter in the applicator design, or even significant modifications in the photon energy spectra above 300 keV. That is not the case for eBT, where a clear dependence on the eBT system and the characteristics of the patient geometry are reported. A complete study specific for each eBT system, including detailed applicator characteristics (size, shape, filtering, among others) and common anatomical locations, should be performed before adopting an existing RBE value.
- 17 June 2022
- Published by Wiley in Medical Physics
- Vol. 49 (8) , 5576-5588
A Monte Carlo study of the relative biological effectiveness in surface brachytherapy
Purpose This work aims to simulate clustered DNA damage from ionizing radiation and estimate the relative biological effectiveness (RBE) for radionuclide (rBT)- and electronic (eBT)-based surface brachytherapy through a hybrid Monte Carlo (MC) approach, using realistic models of the sources and applicators. Methods Damage from ionizing radiation has been studied using the Monte Carlo Damage Simulation algorithm using as input the primary electron fluence simulated using a state-of-the-art MC code, PENELOPE-2018. Two Ir-192 rBT applicators, Valencia and Leipzig, one Co-60 source with a Freiburg Flap applicator (reference source), and two eBT systems, Esteya and INTRABEAM, have been included in this study implementing full realizations of their geometries as disclosed by the manufacturer. The role played by filtration and tube kilovoltage has also been addressed. Results For rBT, an RBE value of about 1.01 has been found for the applicators and phantoms considered. In the case of eBT, RBE values for the Esteya system show an almost constant RBE value of about 1.06 for all depths and materials. For INTRABEAM, variations in the range of 1.12-1.06 are reported depending on phantom composition and depth. Modifications in the Esteya system, filtration, and tube kilovoltage give rise to variations in the same range. Conclusions Current clinical practice does not incorporate biological effects in surface brachytherapy. Therefore, the same absorbed dose is administered to the patients independently on the particularities of the rBT or eBT system considered. The almost constant RBE values reported for rBT support that assumption regardless of the details of the patient geometry, the presence of a flattening filter in the applicator design, or even significant modifications in the photon energy spectra above 300 keV. That is not the case for eBT, where a clear dependence on the eBT system and the characteristics of the patient geometry are reported. A complete study specific for each eBT system, including detailed applicator characteristics (size, shape, filtering, among others) and common anatomical locations, should be performed before adopting an existing RBE value.
- Open Access
- 14 May 2021
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 66 (10) , 105014
A study of Type B uncertainties associated with the photoelectric effect in low-energy Monte Carlo simulations
Purpose. To estimate Type B uncertainties in absorbed-dose calculations arising from the different implementations in current state-of-the-art Monte Carlo (MC) codes of low-energy photon cross-sections (Methods. MC simulations are carried out using three codes widely used in the low-energy domain: PENELOPE-2018, EGSnrc, and MCNP. Three dosimetry-relevant quantities are considered: mass energy-absorption coefficients for water, air, graphite, and their respective ratios; absorbed dose; and photon-fluence spectra. The absorbed dose and the photon-fluence spectra are scored in a spherical water phantom of 15 cm radius. Benchmark simulations using similar cross-sections have been performed. The differences observed between these quantities when different cross-sections are considered are taken to be a good estimator for the corresponding Type B uncertainties. Results. A conservative Type B uncertainty for the absorbed dose ( k = 2) of 1.2%–1.7% (k = 2) of about 1.5% (water and air), and 2% (graphite), diminishing in all materials for larger energies and reaching values about 1% (40–50 keV) and 0.5% (50–75 keV). With respect to their ratios, the only significant Type B uncertainties are observed in the case of the water-to-graphite ratio for energies below 30 keV, being about 0.7% ( k = 2). Conclusions. In contrast with the intermediate (about 500 keV) or high (about 1 MeV) energy domains, Type B uncertainties due to the different cross-sections implementation cannot be considered subdominant with respect to Type A uncertainties or even to other sources of Type B uncertainties (tally volume averaging, manufacturing tolerances, etc). Therefore, the values reported here should be accommodated within the uncertainty budget in low-energy photon dosimetry studies.
- 14 May 2021
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 66 (10) , 105014
Open AccessA study of Type B uncertainties associated with the photoelectric effect in low-energy Monte Carlo simulations
Purpose. To estimate Type B uncertainties in absorbed-dose calculations arising from the different implementations in current state-of-the-art Monte Carlo (MC) codes of low-energy photon cross-sections (Methods. MC simulations are carried out using three codes widely used in the low-energy domain: PENELOPE-2018, EGSnrc, and MCNP. Three dosimetry-relevant quantities are considered: mass energy-absorption coefficients for water, air, graphite, and their respective ratios; absorbed dose; and photon-fluence spectra. The absorbed dose and the photon-fluence spectra are scored in a spherical water phantom of 15 cm radius. Benchmark simulations using similar cross-sections have been performed. The differences observed between these quantities when different cross-sections are considered are taken to be a good estimator for the corresponding Type B uncertainties. Results. A conservative Type B uncertainty for the absorbed dose ( k = 2) of 1.2%–1.7% (k = 2) of about 1.5% (water and air), and 2% (graphite), diminishing in all materials for larger energies and reaching values about 1% (40–50 keV) and 0.5% (50–75 keV). With respect to their ratios, the only significant Type B uncertainties are observed in the case of the water-to-graphite ratio for energies below 30 keV, being about 0.7% ( k = 2). Conclusions. In contrast with the intermediate (about 500 keV) or high (about 1 MeV) energy domains, Type B uncertainties due to the different cross-sections implementation cannot be considered subdominant with respect to Type A uncertainties or even to other sources of Type B uncertainties (tally volume averaging, manufacturing tolerances, etc). Therefore, the values reported here should be accommodated within the uncertainty budget in low-energy photon dosimetry studies.
- Open Access
- 28 May 2020
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 65 (24) , 245026
Depth-dose measurement corrections for the surface electronic brachytherapy beams of an Esteya® unit: a Monte Carlo study
Three different correction factors for measurements with the parallel-plate ionization chamber PTW T34013 on the Esteya electronic brachytherapy unit have been investigated. This chamber type is recommended by AAPM TG-253 for depth-dose measurements in the 69.5 kV x-ray beam generated by the Esteya unit. Monte Carlo simulations using the PENELOPE-2018 system were performed to determine the absorbed dose deposited in water and in the chamber sensitive volume at different depths with a Type A uncertainty smaller than 0.1%. Chamber-to-chamber differences have been explored performing measurements using three different chambers. The range of conical applicators available, from 10 to 30 mm in diameter, has been explored. Using a depth-independent global chamber perturbation correction factor without a shift of the effective point of measurement yielded differences between the absorbed dose to water and the corrected absorbed dose in the sensitive volume of the chamber of up to 1% and 0.6% for the 10 mm and 30 mm applicators, respectively. Calculations using a depth-dependent perturbation factor, including or excluding a shift of the effective point of measurement, resulted in depth-dose differences of about ± 0.5% or less for both applicators. The smallest depth-dose differences were obtained when a shift of the effective point of measurement was implemented, being displaced 0.4 mm towards the center of the sensitive volume of the chamber. The correction factors were obtained with combined uncertainties of 0.4% (k = 2). Uncertainties due to chamber-to-chamber differences are found to be lower than 2%. The results emphasize the relevance of carrying out detailed Monte Carlo studies for each electronic brachytherapy device and ionization chamber used for its dosimetry.
- 28 May 2020
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 65 (24) , 245026
Open AccessDepth-dose measurement corrections for the surface electronic brachytherapy beams of an Esteya® unit: a Monte Carlo study
Three different correction factors for measurements with the parallel-plate ionization chamber PTW T34013 on the Esteya electronic brachytherapy unit have been investigated. This chamber type is recommended by AAPM TG-253 for depth-dose measurements in the 69.5 kV x-ray beam generated by the Esteya unit. Monte Carlo simulations using the PENELOPE-2018 system were performed to determine the absorbed dose deposited in water and in the chamber sensitive volume at different depths with a Type A uncertainty smaller than 0.1%. Chamber-to-chamber differences have been explored performing measurements using three different chambers. The range of conical applicators available, from 10 to 30 mm in diameter, has been explored. Using a depth-independent global chamber perturbation correction factor without a shift of the effective point of measurement yielded differences between the absorbed dose to water and the corrected absorbed dose in the sensitive volume of the chamber of up to 1% and 0.6% for the 10 mm and 30 mm applicators, respectively. Calculations using a depth-dependent perturbation factor, including or excluding a shift of the effective point of measurement, resulted in depth-dose differences of about ± 0.5% or less for both applicators. The smallest depth-dose differences were obtained when a shift of the effective point of measurement was implemented, being displaced 0.4 mm towards the center of the sensitive volume of the chamber. The correction factors were obtained with combined uncertainties of 0.4% (k = 2). Uncertainties due to chamber-to-chamber differences are found to be lower than 2%. The results emphasize the relevance of carrying out detailed Monte Carlo studies for each electronic brachytherapy device and ionization chamber used for its dosimetry.
- 13 November 2019
- Published by Wiley in Medical Physics
- Vol. 47 (2) , 693-702
On the use of the absorbed depth‐dose measurements in the beam calibration of a surface electronic high‐dose‐rate brachytherapy unit, a Monte Carlo‐based study
Purpose: To evaluate the use of the absorbed depth‐dose as a surrogate of the half‐value layer in the calibration of a high‐dose‐rate electronic brachytherapy (eBT) equipment. The effect of the manufacturing tolerances and the absorbed depth‐dose measurement uncertainties in the calibration process are also addressed.Methods: The eBT system Esteya® (Elekta Brachytherapy, Veenendaal, The Netherlands) has been chosen as a proof‐of‐concept to illustrate the feasibility of the proposed method, using its 10 mm diameter applicator. Two calibration protocols recommended by the AAPM (TG‐61) and the IAEA (TRS‐398) for low‐energy photon beams were evaluated. The required Monte Carlo (MC) simulations were carried out using PENELOPE2014. Several MC simulations were performed modifying the flattening filter thickness and the x‐ray tube potential, generating one absorbed depth‐dose curve and a complete set of parameters required in the beam calibration (i.e., HVL, backscatter factor (Bw), and mass energy‐absorption coefficient ratios (µen/ρ)water,air), for each configuration. Fits between each parameter and some absorbed dose‐ratios calculated from the absorbed depth‐dose curves were established. The effect of the manufacturing tolerances and the absorbed dose‐ratio uncertainties over the calibration process were evaluated by propagating their values over the fitting function, comparing the overall calibration uncertainties against reference values. We proposed four scenarios of uncertainty (from 0% to 10%) in the dose‐ratio determination to evaluate its effect in the calibration process.Results: The manufacturing tolerance of the flattening filter (±0.035 mm) produces a change of 1.4% in the calculated HVL and a negligible effect over the Bw, (µen/ρ)water,air, and the overall calibration uncertainty. A potential variation of 14% of the electron energies due to manufacturing tolerances in the x‐ray tube (69.5 ± ~10 keV) generates a variation of 10% in the HVL. However, this change has a negligible effect over the Bw and (µen/ρ)water,air, adding 0.1% to the overall calibration uncertainty. The fitting functions reproduce the data with an uncertainty (k = 2) below 1%, 0.5%, and 0.4% for the HVL, Bw, and (µen/ρ)water,air, respectively. The four studied absorbed dose‐ratio uncertainty scenarios add, in the worst‐case scenario, 0.2% to the overall uncertainty of the calibration process.Conclusions: This work shows the feasibility of using the absorbed depth‐dose curve in the calibration of an eBT system with minimal loss of precision.
- 13 November 2019
- Published by Wiley in Medical Physics
- Vol. 47 (2) , 693-702
On the use of the absorbed depth‐dose measurements in the beam calibration of a surface electronic high‐dose‐rate brachytherapy unit, a Monte Carlo‐based study
Purpose: To evaluate the use of the absorbed depth‐dose as a surrogate of the half‐value layer in the calibration of a high‐dose‐rate electronic brachytherapy (eBT) equipment. The effect of the manufacturing tolerances and the absorbed depth‐dose measurement uncertainties in the calibration process are also addressed.Methods: The eBT system Esteya® (Elekta Brachytherapy, Veenendaal, The Netherlands) has been chosen as a proof‐of‐concept to illustrate the feasibility of the proposed method, using its 10 mm diameter applicator. Two calibration protocols recommended by the AAPM (TG‐61) and the IAEA (TRS‐398) for low‐energy photon beams were evaluated. The required Monte Carlo (MC) simulations were carried out using PENELOPE2014. Several MC simulations were performed modifying the flattening filter thickness and the x‐ray tube potential, generating one absorbed depth‐dose curve and a complete set of parameters required in the beam calibration (i.e., HVL, backscatter factor (Bw), and mass energy‐absorption coefficient ratios (µen/ρ)water,air), for each configuration. Fits between each parameter and some absorbed dose‐ratios calculated from the absorbed depth‐dose curves were established. The effect of the manufacturing tolerances and the absorbed dose‐ratio uncertainties over the calibration process were evaluated by propagating their values over the fitting function, comparing the overall calibration uncertainties against reference values. We proposed four scenarios of uncertainty (from 0% to 10%) in the dose‐ratio determination to evaluate its effect in the calibration process.Results: The manufacturing tolerance of the flattening filter (±0.035 mm) produces a change of 1.4% in the calculated HVL and a negligible effect over the Bw, (µen/ρ)water,air, and the overall calibration uncertainty. A potential variation of 14% of the electron energies due to manufacturing tolerances in the x‐ray tube (69.5 ± ~10 keV) generates a variation of 10% in the HVL. However, this change has a negligible effect over the Bw and (µen/ρ)water,air, adding 0.1% to the overall calibration uncertainty. The fitting functions reproduce the data with an uncertainty (k = 2) below 1%, 0.5%, and 0.4% for the HVL, Bw, and (µen/ρ)water,air, respectively. The four studied absorbed dose‐ratio uncertainty scenarios add, in the worst‐case scenario, 0.2% to the overall uncertainty of the calibration process.Conclusions: This work shows the feasibility of using the absorbed depth‐dose curve in the calibration of an eBT system with minimal loss of precision.
- 2 November 2018
- Published by Wiley in Medical Physics
- Vol. 46 (1) , 356-369
A Monte Carlo‐based dosimetric characterization of Esteya®, an electronic surface brachytherapy unit
Purpose: The purpose of this work is threefold: First, to obtain the phase space of an electronic brachytherapy (eBT) system designed for surface skin treatments. Second, to explore the use of some efficiency enhancing (EFEN) strategies in the determination of the phase space. Third, to use the phase space previously obtained to perform a dosimetric characterization of the Esteya eBT system.Methods: The Monte Carlo study of the 69.5 kVp x‐ray beam of the Esteya® unit (Elekta Brachytherapy, Veenendaal, The Netherlands) was performed with PENELOPE2014. The EFEN strategies included the use of variance reduction techniques and mixed Class II simulations, where transport parameters were fine‐tuned. Four source models were studied varying the most relevant parameters characterizing the electron beam impinging the target: the energy spectrum (mono‐energetic or Gaussian shaped), and the electron distribution over the focal spot (uniform or Gaussian shaped). Phase spaces obtained were analyzed to detect differences in the calculated data due to the EFEN strategy or the source configuration. Depth dose curves and absorbed dose profiles were obtained for each source model and compared to experimental data previously published.Results: In our EFEN strategy, the interaction forcing variance reduction (VRIF) technique increases efficiency by a factor ~20. Tailoring the transport parameters values (C1 and C2) does not increase the efficiency in a significant way. Applying a universal cutoff energy EABS of 10 keV saves 84% of CPU time while showing negligible impact on the calculated results. Disabling the electron transport by imposing an electron energy cutoff of 70 keV (except for the target) saves an extra 8% (losing in the process 1.2% of the photons). The Gaussian energy source (FWHM = 10%, centered at the nominal kVp, homogeneous electron distribution) shows characteristic K‐lines in its energy spectrum, not observed experimentally. The average photon energy using an ideal source (mono‐energetic, homogeneous electron distribution) was 36.19 ± 0.09 keV, in agreement with the published measured data of 36.2 ± 0.2 keV. The use of a Gaussian‐distributed electron source (mono‐energetic) increases the penumbra by 50%, which is closer to the measurement results. The maximum discrepancy of the calculated percent depth dose with the corresponding measured values is 4.5% (at the phantom surface, less than 2% beyond 1 mm depth) and 5% (for the 80% of the field) in the dose profile. Our results agree with the findings published by other authors and are consistent within the expected Type A and B uncertainties.Conclusions: Our results agree with the published measurement results within the reported uncertainties. The observed differences in PDD, dose profiles, and photon spectrum come from three main sources of uncertainty: intermachine variations, measurements, and Monte Carlo calculations. It has been observed that a mono‐energetic source with a Gaussian electron distribution over the focal spot is a suitable choice to reproduce the experimental data.
- 2 November 2018
- Published by Wiley in Medical Physics
- Vol. 46 (1) , 356-369
A Monte Carlo‐based dosimetric characterization of Esteya®, an electronic surface brachytherapy unit
Purpose: The purpose of this work is threefold: First, to obtain the phase space of an electronic brachytherapy (eBT) system designed for surface skin treatments. Second, to explore the use of some efficiency enhancing (EFEN) strategies in the determination of the phase space. Third, to use the phase space previously obtained to perform a dosimetric characterization of the Esteya eBT system.Methods: The Monte Carlo study of the 69.5 kVp x‐ray beam of the Esteya® unit (Elekta Brachytherapy, Veenendaal, The Netherlands) was performed with PENELOPE2014. The EFEN strategies included the use of variance reduction techniques and mixed Class II simulations, where transport parameters were fine‐tuned. Four source models were studied varying the most relevant parameters characterizing the electron beam impinging the target: the energy spectrum (mono‐energetic or Gaussian shaped), and the electron distribution over the focal spot (uniform or Gaussian shaped). Phase spaces obtained were analyzed to detect differences in the calculated data due to the EFEN strategy or the source configuration. Depth dose curves and absorbed dose profiles were obtained for each source model and compared to experimental data previously published.Results: In our EFEN strategy, the interaction forcing variance reduction (VRIF) technique increases efficiency by a factor ~20. Tailoring the transport parameters values (C1 and C2) does not increase the efficiency in a significant way. Applying a universal cutoff energy EABS of 10 keV saves 84% of CPU time while showing negligible impact on the calculated results. Disabling the electron transport by imposing an electron energy cutoff of 70 keV (except for the target) saves an extra 8% (losing in the process 1.2% of the photons). The Gaussian energy source (FWHM = 10%, centered at the nominal kVp, homogeneous electron distribution) shows characteristic K‐lines in its energy spectrum, not observed experimentally. The average photon energy using an ideal source (mono‐energetic, homogeneous electron distribution) was 36.19 ± 0.09 keV, in agreement with the published measured data of 36.2 ± 0.2 keV. The use of a Gaussian‐distributed electron source (mono‐energetic) increases the penumbra by 50%, which is closer to the measurement results. The maximum discrepancy of the calculated percent depth dose with the corresponding measured values is 4.5% (at the phantom surface, less than 2% beyond 1 mm depth) and 5% (for the 80% of the field) in the dose profile. Our results agree with the findings published by other authors and are consistent within the expected Type A and B uncertainties.Conclusions: Our results agree with the published measurement results within the reported uncertainties. The observed differences in PDD, dose profiles, and photon spectrum come from three main sources of uncertainty: intermachine variations, measurements, and Monte Carlo calculations. It has been observed that a mono‐energetic source with a Gaussian electron distribution over the focal spot is a suitable choice to reproduce the experimental data.
- 1 January 2016
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 107, 191-194
Characterization of hemispherical area X-ray detector based on set of proportional counters with needle anodes
- 1 January 2016
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 107, 191-194
Characterization of hemispherical area X-ray detector based on set of proportional counters with needle anodes
- Open Access
- 8 July 2015
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 16 (4) , 3-17
Brachytherapy treatment planning commissioning: effect of the election of proper bibliography and finite size of TG‐43 input data on standard treatments
The aim of this work is to evaluate the performance of a commercial brachytherapy treatment planning system (TPS) with TG-43 Vendors Input Data (VID), analyze possible discrepancies with respect to a proper reference source and its implications for standard treatments, and judge the effectiveness of certain widespread recommended quality controls to find potential errors related with the interpolations of TG-43 VID tables. The TPS evaluated was a BrachyVision 8.6 loaded with TG-43 VID for a VariSource high-dose-rate source (Vs2000). The reference data chosen were the TG-43 data published in the literature. In the first step, we compared TG-43 VID with respect to the chosen reference data. Next, we used percent dose-rate differences in a point array matrix to compare the outcomes of the TPS on standard treatment setup with respect to an in-house developed program (MATLAB R2009a-based) loaded with the chosen full TG-43 reference data. The cases with major discrepancies were evaluated using the gamma-index analysis. The comparison with the reference data indicated a lack of sample in the angles between near to the tip (between ) and cable ( ) of the , which causes a dose underestimation of approximately 17% in the investigated points due to inaccurate interpolations. The differences over 2% encompassed approximately 17% of the surrounding source volume. These results have special relevance in treatment using one applicator with a few dwell steps or in Fletcher treatments where 10% dose underestimates were identified within the tumor or in organs at risk, respectively. Our results suggest that the differences found in the TPS under study are created by a lack of information on the angles in high-gradient zones in the , which generates important differences in dosimetric results. In contrast, the gamma analysis shows very good results (between 90% and 100% of passed points) in the analyzed treatments (one dwell and Fletcher). Further studies are required to exclude the possibility of finding noticeable effects in the DVH of treatment plans caused by the discrepancies here described. To achieve more strict control over the TPS dose-rate calculation, we recommend using QA test thinking in a source with nonaxial symmetry, adding a control point on the angles of the high-dose gradient zones (e.g., between 0° and 15° and between 165° and 180°). More studies are required to achieve full understanding of the clinical implication of such discrepancies. PACS number: 87.55.Qr- 8 July 2015
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 16 (4) , 3-17
Open AccessBrachytherapy treatment planning commissioning: effect of the election of proper bibliography and finite size of TG‐43 input data on standard treatments
The aim of this work is to evaluate the performance of a commercial brachytherapy treatment planning system (TPS) with TG-43 Vendors Input Data (VID), analyze possible discrepancies with respect to a proper reference source and its implications for standard treatments, and judge the effectiveness of certain widespread recommended quality controls to find potential errors related with the interpolations of TG-43 VID tables. The TPS evaluated was a BrachyVision 8.6 loaded with TG-43 VID for a VariSource high-dose-rate source (Vs2000). The reference data chosen were the TG-43 data published in the literature. In the first step, we compared TG-43 VID with respect to the chosen reference data. Next, we used percent dose-rate differences in a point array matrix to compare the outcomes of the TPS on standard treatment setup with respect to an in-house developed program (MATLAB R2009a-based) loaded with the chosen full TG-43 reference data. The cases with major discrepancies were evaluated using the gamma-index analysis. The comparison with the reference data indicated a lack of sample in the angles between near to the tip (between ) and cable ( ) of the , which causes a dose underestimation of approximately 17% in the investigated points due to inaccurate interpolations. The differences over 2% encompassed approximately 17% of the surrounding source volume. These results have special relevance in treatment using one applicator with a few dwell steps or in Fletcher treatments where 10% dose underestimates were identified within the tumor or in organs at risk, respectively. Our results suggest that the differences found in the TPS under study are created by a lack of information on the angles in high-gradient zones in the , which generates important differences in dosimetric results. In contrast, the gamma analysis shows very good results (between 90% and 100% of passed points) in the analyzed treatments (one dwell and Fletcher). Further studies are required to exclude the possibility of finding noticeable effects in the DVH of treatment plans caused by the discrepancies here described. To achieve more strict control over the TPS dose-rate calculation, we recommend using QA test thinking in a source with nonaxial symmetry, adding a control point on the angles of the high-dose gradient zones (e.g., between 0° and 15° and between 165° and 180°). More studies are required to achieve full understanding of the clinical implication of such discrepancies. PACS number: 87.55.Qr - 21 January 2015
- Published by Wiley in X-Ray Spectrometry
- Vol. 44 (2) , 69-74
Determination of kernel emission spectrum of a mini X‐ray tube for EDXRF applications
Knowing the spectrum near the output of the relatively new mini X‐ray tube (MXRT) commercial models is fundamentally important in energy‐dispersive X‐ray fluorescence scan images, especially in the in vivo applications. This information is relevant for determining the absorbed dose during a measurement and for absolute quantification by a fundamental parameter method. However, it is not possible to measure it directly using a silicon drift detector (SDD) given the high saturation in the counts. In this work, an experimental methodology is developed for determining the kernel spectrum emitted by the MXRT, enabling the quantification of its energy flux density over short distances. Different distances were used: source–detector, solid emission angle (collimation), attenuation characteristics of the medium (air), and in a vacuum, within an energy range of 1–40 keV, to determine the X‐ray tube spectrum. The spectrum is measured by an SDD, taking its efficiency and dead time into account. In order to verify the method, a spectrum that is rebuilt starting with the kernel is compared, under the same conditions, with a reference spectrum that is directly measured in air and with a theoretical spectrum obtained by the Ebel model. The results are consistent and validate the methodology employed in this work. Additionally, low‐energy peaks were detected, corresponding to the tube material's L lines, which are not present in the original spectrum reported by the manufacturer. Copyright © 2015 John Wiley & Sons, Ltd.
- 21 January 2015
- Published by Wiley in X-Ray Spectrometry
- Vol. 44 (2) , 69-74
Determination of kernel emission spectrum of a mini X‐ray tube for EDXRF applications
Knowing the spectrum near the output of the relatively new mini X‐ray tube (MXRT) commercial models is fundamentally important in energy‐dispersive X‐ray fluorescence scan images, especially in the in vivo applications. This information is relevant for determining the absorbed dose during a measurement and for absolute quantification by a fundamental parameter method. However, it is not possible to measure it directly using a silicon drift detector (SDD) given the high saturation in the counts. In this work, an experimental methodology is developed for determining the kernel spectrum emitted by the MXRT, enabling the quantification of its energy flux density over short distances. Different distances were used: source–detector, solid emission angle (collimation), attenuation characteristics of the medium (air), and in a vacuum, within an energy range of 1–40 keV, to determine the X‐ray tube spectrum. The spectrum is measured by an SDD, taking its efficiency and dead time into account. In order to verify the method, a spectrum that is rebuilt starting with the kernel is compared, under the same conditions, with a reference spectrum that is directly measured in air and with a theoretical spectrum obtained by the Ebel model. The results are consistent and validate the methodology employed in this work. Additionally, low‐energy peaks were detected, corresponding to the tube material's L lines, which are not present in the original spectrum reported by the manufacturer. Copyright © 2015 John Wiley & Sons, Ltd.